Erste Asset Management Gmb H Neurocrine Biosciences Inc Transaction History
Erste Asset Management Gmb H
- $8.35 Trillion
- Q3 2024
A detailed history of Erste Asset Management Gmb H transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Erste Asset Management Gmb H holds 23,800 shares of NBIX stock, worth $2.92 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
23,800Holding current value
$2.92 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
616Shares Held
94.2MCall Options Held
557KPut Options Held
545K-
Black Rock Inc. New York, NY14.2MShares$1.74 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.23 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$633 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$316 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$229 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...